Cargando…
Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring
BACKGROUND: The FluoroSpot assay, an advancement of the ELISpot assay, enables simultaneous measurement of different analytes secreted at a single-cell level. This allows parallel detection of several cytokines secreted by immune cells upon antigen recognition. Easier standardization, higher sensiti...
Autores principales: | Körber, Nina, Behrends, Uta, Hapfelmeier, Alexander, Protzer, Ulrike, Bauer, Tanja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906590/ https://www.ncbi.nlm.nih.gov/pubmed/27297580 http://dx.doi.org/10.1186/s12967-016-0932-7 |
Ejemplares similares
-
Evaluation of T-activated proteins as recall antigens to monitor Epstein–Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting
por: Körber, Nina, et al.
Publicado: (2020) -
Triple Cytokine FluoroSpot Analysis of Human Antigen-Specific IFN-γ, IL-17A and IL-22 Responses
por: Dillenbeck, Tomas, et al.
Publicado: (2014) -
Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays
por: Janetzki, Sylvia, et al.
Publicado: (2014) -
FluoroSpot Analysis of TLR-Activated Monocytes Reveals Several Distinct Cytokine-Secreting Subpopulations
por: Smedman, C, et al.
Publicado: (2012) -
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses
por: Tiezzi, Camilla, et al.
Publicado: (2023)